August 11, 2020 - The Baylor Scott & White Research Institute last Wednesday enrolled the first patient in the world for the ACTIV-3 clinical trial just one day after the initiative was launched by the National Institutes of Health (NIH). A second patient was enrolled the following day. The NIH ACTIV-3 Trial is part of the Accelerating COVID-19 Therapeutic … [Read more...]
NIH to use Premier Healthcare Database to evaluate wider health impacts of COVID-19
July 30, 2020 - Premier Inc. (Charlotte, NC) announced a data licensing agreement with the National Institutes of Health (NIH). The agreement grants researchers in the Critical Care Medicine Department at the NIH Clinical Center access to the Premier Healthcare Database (PHD) to conduct research on the impact of COVID-19 on patients across the U.S. Researchers at the NIH … [Read more...]